Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)

Description

The goal of the project is to evaluate whether donepezil + cognitive remediation therapy is superior to placebo in reducing heavy drinking in patients with alcohol use disorder in a double-blind, placebo-controlled trial.

Conditions

Alcohol Use Disorder

Study Overview

Study Details

Study overview

The goal of the project is to evaluate whether donepezil + cognitive remediation therapy is superior to placebo in reducing heavy drinking in patients with alcohol use disorder in a double-blind, placebo-controlled trial.

The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder

Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)

Condition
Alcohol Use Disorder
Intervention / Treatment

-

Contacts and Locations

West Haven

VA Connecticut Healthcare System, West Haven, Connecticut, United States, 06516

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Males and females 18-80 years of age
  • 2. Fluency in English and a 6th grade or higher reading level
  • 3. Meets the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for a current alcohol use disorder (subjects should have a primary alcohol use disorder \[AUD\] diagnosis, but may have concurrent occasional use of other substances)
  • 4. Last alcohol use and at least one heavy drinking day within the past 30 days
  • 5. Willingness to attend follow-up assessments at 13 weeks
  • 6. Willingness to submit to Urine Toxicology screenings
  • 1. Lifetime diagnosis of a psychotic disorder, not induced by drug use
  • 2. Current treatment with opioids or benzodiazepines, which may affect new learning
  • 3. Involvement in a legal case that may lead to incarceration during the study period
  • 4. Residential plans that would interfere with participation
  • 5. Medical illness that may significantly compromise cognition (e.g., Parkinson's, Alzheimer's, Huntington's chorea, moderate or greater TBI)
  • 6. An uncorrected sensory impairment (hearing or sight) that would seriously interfere with cognitive training
  • 7. Pre-morbid intelligence quotient (IQ) estimate below 70
  • 8. Unstable housing or lack of commitment to staying within a geographic area that would make follow-up unlikely
  • 9. Unwillingness to provide contact information of someone who can help study staff contact the subjects in the event that study staff are unable to maintain contact directly
  • 10. Allergy to donepezil
  • 11. Unstable cardiovascular disease or unstable medical condition-clinically determined by a physician
  • 12. Imminent suicidal or homicidal risk
  • 13. Pregnant or nursing women, positive pregnancy test, or inadequate birth control methods in women of childbearing potential

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

VA Connecticut Healthcare System,

Gihyun Yoon, MD, PRINCIPAL_INVESTIGATOR, Yale University, VA Connecticut Healthcare System

Study Record Dates

2026-05-31